Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-Human EPHA4 Antibody (MEDI-542)

Catalog #:   DHF05302 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DHF05302

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Tyrosine-protein kinase receptor SEK, Tyrosine-protein kinase TYRO1, Ephrin type-A receptor 4, TYRO1, EPHA4, EPH-like kinase 8, hEK8, SEK, EK8, HEK8

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P54764

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

MEDI-542, MEDI542, MEDI 542

Clone ID

MEDI-542

Data Image
References

Eph Receptor Tyrosine Kinases Are Functional Entry Receptors for Murine Gammaherpesvirus 68., PMID:40501621

Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study., PMID:39621188

EphA4 Targeting Peptide-Conjugated Extracellular Vesicles Rejuvenates Adult Neural Stem Cells and Exerts Therapeutic Benefits in Aging Rats., PMID:39288278

The pro-tumoral and anti-tumoral roles of EphA4 on T regulatory cells and tumor associated macrophages during HNSCC tumor progression., PMID:39211197

Corrigendum to "Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer" [Biochem. Biophys. Res. Commun. 680 (2023) 161-170]., PMID:37839952

Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer., PMID:37741263

Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome., PMID:37587118

Myelination defects in the medial prefrontal cortex of Fkbp5 knockout mice., PMID:33410216

EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes., PMID:30817459

RANKL, Ephrin-Eph and Wnt10b are key intercellular communication molecules regulating bone remodeling in autologous transplanted goldfish scales., PMID:29886255

Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus., PMID:29292384

EphA4 protein promotes invasion in clear cell renal cell carcinomas., PMID:31966534

High expression of EphA4 is associated with invasion and lymph node metastasis in colorectal carcinomas., PMID:31966851

Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist., PMID:28747680

Identification and characterization of Nanobodies targeting the EphA4 receptor., PMID:28526745

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery., PMID:28165374

[Estimation of the diagnostic potential of APOD, PTOV1, and EPHA4 for prostatic neoplasms]., PMID:27804940

EPHA4-FC TREATMENT REDUCES ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY BY INHIBITING VASCULAR PERMEABILITY., PMID:26771935

Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination., PMID:26687980

EPHA4 is overexpressed but not functionally active in Sézary syndrome., PMID:26376612

Development of a Trispecific Antibody Designed to Simultaneously and Efficiently Target Three Different Antigens on Tumor Cells., PMID:26176328

Distinct polarity cues direct Taz/Yap and TGFβ receptor localization to differentially control TGFβ-induced Smad signaling., PMID:25758863

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation., PMID:25556233

Characterization of cytoplasmic polyadenylation element binding 2 protein expression and its RNA binding activity., PMID:25483308

Ephrin-A2 and -A3 are negative regulators of the regenerative potential of Möller cells., PMID:25269910

Upregulation of axon guidance molecules in the adult central nervous system of Nogo-A knockout mice restricts neuronal growth and regeneration., PMID:24103058

Acute delivery of EphA4-Fc improves functional recovery after contusive spinal cord injury in rats., PMID:23557244

EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE)., PMID:23390555

Partial change in EphA4 knockout mouse phenotype: loss of diminished GFAP upregulation following spinal cord injury., PMID:22824304

The N-end rule pathway counteracts cell death by destroying proapoptotic protein fragments., PMID:22670058

EphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in mice., PMID:21931787

Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice., PMID:21282286

Preparation of mouse brain tissue for immunoelectron microscopy., PMID:20689505

Developmental expression of Eph and ephrin family genes in mammalian small intestine., PMID:20112066

EphA4 is localized in clathrin-coated and synaptic vesicles in adult mouse brain., PMID:20067584

Expression of PTPRO in the interneurons of adult mouse olfactory bulb., PMID:19924828

A review of published reports on neuroprotection in spinal cord injury., PMID:19597522

Upregulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss., PMID:18055806

Venous identity is lost but arterial identity is not gained during vein graft adaptation., PMID:17463332

Localization of EphA4 in axon terminals and dendritic spines of adult rat hippocampus., PMID:17299751

Blocking EphA4 upregulation after spinal cord injury results in enhanced chronic pain., PMID:16959251

Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains., PMID:16365308

[Preparation and analysis of monoclonal antibody against EphA4 peptide]., PMID:16320581

Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets., PMID:15994237

Paraplegic mice are leading to new advances in spinal cord injury research., PMID:15809672

Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection., PMID:15681844

Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice., PMID:15537875

Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin., PMID:12907451

EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells., PMID:12775584

EphA4 provides repulsive signals to developing cochlear ganglion neurites mediated through ephrin-B2 and -B3., PMID:12761826

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-Human EPHA4 Antibody (MEDI-542) [DHF05302]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only